OHR Pharmaceutical
About:
OHR Pharmaceutical develops products for the treatment of cancer cachexia and wet age-related macular degeneration.
Website: http://ohrpharmaceutical.com
Twitter/X: OhrPharma
Description:
OHR Pharmaceutical is a development-stage biotechnology company that focuses on the development of products for the treatment of cancer cachexia (multi-symptom wasting disorder) and wet- age-related macular degeneration. It was founded in 2009 and is headquartered in New York, New York.
Total Funding Amount:
$47.9M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
New York, New York, United States
Founded Date:
2009-01-01
Contact Email:
info(AT)ohrpharmaceutical.com
Founders:
Irach Taraporewala
Number of Employees:
1-10
Last Funding Date:
2017-04-04
IPO Status:
Public
Industries:
© 2025 bioDAO.ai